why choose us

First received: November 18, 2025

Clinical Trial: Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Cryopyrin-associated Periodic Syndromes (CAPS)

Study Type: INTERVENTIONAL


Official Title: A Phase 1b, Open-label, Single-arm Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS)

Brief Summary: This study will evaluate the efficacy, safety, tolerability and pharmacokinetics of JTE-162 administered once daily for 2 weeks in subjects with cryopyrin-associated periodic syndrome (CAPS)

Read more